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Abstract
Plasmodium falciparum is an obligate intracellular parasite and the leading cause of severe malaria responsible for tre-
mendous morbidity and mortality particularly in sub-Saharan Africa. Successful completion of the P. falciparum
genome sequencing project in 2002 provided a comprehensive foundation for functional genomic studies on this
pathogen in the following decade.Over this period, a large spectrum of experimental approaches has been deployed
to improve and expand the scope of functionally annotated genes. Meanwhile, rapidly evolving methods of systems
biology have also begun to contribute to a more global understanding of various aspects of the biology and patho-
genesis of malaria. Herein we provide an overview on metabolic modelling, which has the capability to integrate
information from functional genomics studies in P. falciparum and guide future malaria research efforts towards the
identification of novel candidate drug targets.
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INTRODUCTION
According to the recent ‘World Malaria Report’ by
the World Health Organization, malaria remains a
major healthcare issue, being responsible for more
than 200 million cases and hundreds of thousands of
deaths in 2010 alone [1]. An efficient and cost-effect-
ive artemisinin-based treatment is now available, but
the emergence of resistance in malaria parasites, as a
result of drug treatments, urges the development of
medicines with new targets and novel mechanisms of
action. Despite tremendous research efforts and the
passing of a decade since the publication of the
Plasmodium falciparum genome sequence [2], about a
half of the genes still remain annotated as coding for
‘hypothetical proteins’ or ‘conserved hypothetical
proteins’ [3]. These genes, and especially those re-
stricted to Plasmodium or apicomplexan species, are
of particular interest as their unique nucleotide se-
quences may provide higher selectivity for new anti-
parasitic drugs. However, in the absence of tools for
high-throughput gene knockdown such as RNAi [4],
the identification and validation of the essentiality of
these genes for the parasite remains a major bottleneck
[3]. Available experimental approaches for establish-
ing gene essentiality in P. falciparum are cumbersome
due to several unique properties of the pathogen.
First, it possesses an extremely AT-rich genome
along with an unusually low frequency of
StepanTymoshenko is a PhD student at the E´cole Polytechnique Fe´de´rale de Lausanne. He is involved in an interdisciplinary model-
driven research project that aims at the elucidation of poorly understood aspects in the metabolism of Plasmodium falciparum.
RebeccaOppenheim is a PhD student at the University of Geneva working on the central carbon metabolism of the apicomplexan
parasites Toxoplasma gondii and Plasmodium berghei.
DominiqueSoldati-Favre is a professor in the faculty of Medicine of the University of Geneva and the head of a laboratory focusing
on motility, host cell attachment, invasion and strategies that allow intracellular proliferation of apicomplexan parasites.
Vassily Hatzimanikatis is an associate professor at the E´cole Polytechnique Fe´de´rale de Lausanne and head of the Laboratory of
Computational Systems Biotechnology. His research interests are in the areas of systems biology, bioinformatics, and complexity of
biological systems.
Corresponding author. Stepan Tymoshenko, Institute of Chemical Engineering, Laboratory of Computational Systems Biotechnology,
E´cole Polytechnique Fe´de´rale de Lausanne, CH-1015, Switzerland. Tel: þ41 (0) 21 693 98 69; Fax: þ41 (0) 21 693 98 75;
E-mail:stepan.tymoshenko@epfl.ch
BRIEFINGS IN FUNCTIONAL GENOMICS. page 1 of 12 doi:10.1093/bfgp/elt017
 The Author 2013. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which
permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
 Briefings in Functional Genomics Advance Access published June 22, 2013
 by Stepan Tym
oshenko on A
ugust 8, 2013
http://bfg.oxfordjournals.org/
D
ow
nloaded from
 
homologous recombination, which makes it refrac-
tory to genetic manipulation such as gene replace-
ment [3]. Second, in vitro cultivation is a delicate
process [5] that is still mainly restricted to the intraer-
ythrocytic stages. Third, the limitation of using pri-
mates as an animal model makes the invivo assessment
of gene essentiality very limited and expensive.
Nevertheless, emerging experimental breakthroughs
hold promises for cost-effective gene knockdown
strategies of the P. falciparum essential genes at a high-
throughput scale [6, 7]. In this context, there is a need
to list genes of immediate interest, which should be
validated as antimalarial targets once affordable ex-
perimental means are available.
Metabolic modelling is a modern approach of sys-
tems biology that, among several other applications,
has been extensively exerted to predict gene essen-
tiality in various bacteria including a number of
pathogenic species [8]. Computational (i.e. in silico)
metabolic models offer a cost-effective pipeline to
identify putatively indispensable metabolic functions
that, in the case of pathogens, represent potential
targets for medical intervention [9]. Eight years
after the publication of the first computational
model of a tentative metabolic network of P. falcip-
arum, it has become evident that reconstruction and
analysis of in silico models is a valuable tool for study-
ing various aspects of the pathogen [10–14]. In this
study, we aim to review and provide an outlook on
the current state and contribution of in silico meta-
bolic modelling efforts to functional genomics
studies on the deadly malaria parasite.
THE PATH FROMMETABOLIC
MAPSTO ‘CONTEXT FOR
CONTENT’MODELS
With the constantly decreasing cost of high-
throughput measurements, the tendency to generate
very large -omics datasets is emerging and this holds
also true for P. falciparum [15]. There are two distinct
approaches to high-throughput measurements: hy-
pothesis-driven studies generate large datasets to
prove or falsify a hitherto existing hypothesis, while
hypothesis-free studies primarily rely on a thorough
analysis of datasets without presumptions aiming at
the formulation of conclusions and testable hypoth-
eses. Importantly, hypothesis-free approaches require
an appropriate context, i.e. a framework of related
prior knowledge, within which an obtained dataset
can be interpreted. In the case of functional genomic
studies, in silico metabolic models have been shown
to provide such context, thus enabling researchers
to use available datasets (i.e. content) to improve
and challenge the models and to derive additional,
non-intuitive insights. In particular, this need for an
explicit, up-to-date context is a driving force for
the progress from a scope of generic biochemical
knowledge to organism-specific (or life stage specific)
metabolic networks, which we will discuss further.
In the past two decades, several databases of bio-
chemical reactions and metabolic pathways have been
developed to provide a systematic and comprehensive
overview of metabolism. A pertinent example is the
Kyoto Encyclopedia of Genes and Genomes (KEGG)
Pathway Database [16], which has established itself as
an encyclopedia of biochemical knowledge and the
first point of reference for numerous academic and
industrial researches. However, KEGG and similar
large databases are more universal than organism-
specific, thus they do not cover some crucial aspects
of the P. falciparum metabolism, such as cofactor util-
ization, compartmentalization and proteins involved
in the transport of metabolites. The web-resource
Malaria Parasite Metabolic Pathways (MPMP) is es-
sentially the product of an extensive manual revision
of KEGG maps according to known and recently es-
tablished metabolic features of the P.falciparum intraer-
ythrocytic life stage. Furthermore, integration with
other web-resources facilitates quick access to add-
itional information and related primary literature
[17]. MPMP is probably the most comprehensive
and up-to-date knowledge database on P. falciparum’s
metabolism, but unfortunately the lack of any appli-
cation-programming interface limits the access of a
broad research community to this high-quality data.
Utility of MPMP for research purposes has been
demonstrated via interpretation of the expression pat-
terns for the genes involved in the pentose-phosphate
pathway using the corresponding maps [18]. This led
the authors to postulate that the oxidative part of the
pathway is predominantly active during the early stage
of the intraerythrocytic replication cycle, whereas the
non-oxidative part is activated only during the later
stages [18]. In contrast to this approach, further at-
tempts to comprehend metabolic fluxes in the malaria
parasite aimed at going beyond the study of a particu-
lar pathway and ultimately led to the reconstruction
of large-scale models with hundreds of metabolites
and interconnected reactions involved [10–14].
Graph-based models (GBMs) were built to com-
prehend and analyse the metabolic capabilities of
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P. falciparum in a systematic manner. GBMs represent
metabolism as graphs with nodes (to denote metab-
olites) and links between them (respective metabolic
reactions) [19]. The links only represent the possibility
of interconversion for a particular metabolite into an-
other one (justified by the correspondingly annotated
genes), regardless of all the properties of the reaction
including its stoichiometry. A natural advantage of
GBMs is that they require minimal input information
and can assess well-annotated parts of a given meta-
bolic network while skipping unclear ones. However,
such representation of a metabolic network without
capturing its mass-balance property is not a suitable
framework for incorporation of experimental infor-
mation, thus making the scope of GBM-based meth-
ods in metabolic modelling rather limited. Nowadays,
graph-based metabolic reconstructions and topo-
logical analysis are largely obsolete and have been
replaced by more comprehensive constraint-based
approaches.
Over the past decade flux-balance analysis (FBA)
has been established as a leading approach for study-
ing constraint-based models (CBMs) of cellular me-
tabolism [20]. Constraint-based metabolic models for
FBA are based on two-dimensional arrays, where
each row represents a metabolite and each column
corresponds to a reaction, which, as a rule, is linked
to a certain enzyme and gene in the organism [21].
Each intersection of row and column contains a nu-
merical value standing for the stoichiometric coeffi-
cient of a given metabolite in a given reaction. Such
notation enables the explicit and quantitative de-
scription of a metabolic network and allows the
imposing of the first basic constraint—mass balance.
A model that only accounts for mass balance is lar-
gely undefined and further constraints are imposed to
enrich the range of feasible solutions with biologic-
ally realistic ones. The scope of additional constraints
is constantly growing and currently includes thermo-
dynamic (tFBA), regulatory (rFBA) and other con-
straints inherent in cellular metabolism (reviewed in
[22]) and constraints inferred from experimental data.
CBMs, unlike GBMs, do require a pre-defined
objective towards which utilization of available sub-
strates should be optimized [23]. A common object-
ive function for fast-growing cells is the biomass
reaction (other plausible objectives are reviewed in
[24]). It represents cellular replication as a reaction
that consumes pre-defined amount of metabolites
referred to as precursors of biomass. Existence of a
solution implies that the stoichiometric array
describes at least one uninterrupted pathway that
leads to the transformation of externally supplied
substrates into biomass precursor for each of the
precursors. To satisfy this requirement, the model-
building process often involves the inclusion of ‘or-
phan reactions’, for which no enzyme-coding gene
has been annotated yet [25].
A conventional reconstruction workflow [25]
clearly defines the list of enzymes that should be
found in the genome to complete the pathways
and meet experimentally observed metabolic beha-
viour. With this approach, putative metabolic func-
tions have been proposed for 17 genes of Leishmania
major, which previously had no functional annota-
tions [26]. Although these assignments, often based
on moderate sequence identity, are not sufficient
proofs of the suggested functions, they do represent
a set of testable hypotheses for experimental valid-
ation. Such a list of orphan reactions provides an
invaluable guidance for functional genomics studies
into P.falciparum that has more than 2000 genes with-
out even putative functional annotation.
One of the most important applications for CBMs
of pathogenic species is the capability to predict po-
tential vulnerabilities in their metabolism [9]. Often
metabolic networks are redundant and contain more
than one chain of reactions to produce certain bio-
mass precursors. To explore this redundancy, FBA
enables an attempt at the simulation of growth
when each of the reactions in the model is removed
in a one-at-a-time manner. Whenever production of
biomass is blocked without a certain reaction, the
latter is classified as essential. In a similar manner,
FBA can simulate outcomes of withdrawal of
enzymes or genes by attempting to simulate growth
when utilization of all the reactions associated with an
enzyme or gene is disabled. We refer the reader to a
comprehensive publication on insilico essentiality stu-
dies in the CBM of Saccharomyces cerevisiae [27] for
further details and examples.
OUTLOOKOF IN SILICO
METABOLICMODELS FOR
P. FALCIPARUM
Several studies to date have focused on the compre-
hensive reconstruction of the metabolic network
of P. falciparum (Table 1). Early studies produced
several GBMs [11, 14, 28] that considered the
set of metabolic activities reported at the time with-
out taking into account information on the
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compartments they occur in nor the differences
in life-stage-specific metabolism of the pathogen.
As mentioned before, without consistency in mass-
balance relationships, these models were not suitable
for integration of experimental data and allowed
only qualitative predictions of gene essentiality.
Nevertheless, during the reconstruction process
putative functions were suggested for hundreds of
genes previously annotated as coding for a ‘hypo-
thetical protein’ [14]. These first modelling efforts
gave a broad overview of the metabolic capabilities
of P. falciparum annotated in its genome when
compared with the expected ones and provided a
solid foundation for building the modern, more
comprehensive reconstructions discussed hereafter.
Using a constraint-based approach, Huthmacher
et al. [12] assembled the first compartmentalized,
mass-balanced and life-stage-specific model of
P.falciparummetabolism. Through insilico simulations,
the authors identified enzymatic activities that are
essential for proliferation of the parasite. Thirty
of the in silico essential reactions were catalyzed by
enzymes with no homologues in the human prote-
ome (E-value> 0.075). These were ranked as targets
of particular interest based on evidence of activity
during the multiple stages of P. falciparum life cycle
studied and/or the presence in SuperTarget database
[29] as candidates for treatment of other infections
[12]. Furthermore, the natural environment of the
parasite was simulated by embedding its CBM into
the metabolic reconstruction of a human erythro-
cyte. This limited the substrate accessibility to only
those available in the host cell milieu. Such con-
straints at the cellular interface and constraints on
reaction fluxes, deduced from gene expression pro-
files (obtained on different life stages), not only
allowed the model to retrieve known directions of
metabolite exchanges between the host cell and the
parasite, but also identified several inconsistencies
with experimental data, which need further investi-
gation [12].
The second CBM developed independently by
Plata et al. [13] also took account of compartmental-
ization of the intracellular space and mass-balance
constraints. The results of gene deletions performed
in silico were found to be in correspondence with
reports in the primary literature: 100% agreement
when compared with gene deletion studies and
70% in case of enzymatic inhibition experiments.
Comparison of the number of essential genes in
the models of P. falciparum and S. cerevisiae confirmed
the notion that the parasite likely possesses signifi-
cantly lower metabolic flexibility to bypass single-
gene deletions when compared with free-living
organisms with similar genome sizes [13]. Forty
genes were suggested as potential drug targets due
to their in silico essentiality and extremely low or
absent sequence identity to human proteins [13].
The essentiality of one of these genes encoding the
nicotinate mononucleotide adenylyltransferase was
verified using an experimental inhibitor, which
caused an arrest of P. falciparum proliferation at an
IC50 of 50mM in in vitro culture [13]. In addition,
Plata etal. [13] were the first to report insilico double-
gene deletion simulations in P. falciparum leading to
the identification of 16 pairs of genes that were pre-
dicted as non-essential by single-gene knockout
simulation but resulted in a dramatic impairment of
the metabolism if targeted simultaneously.
Holzhutter and co-workers have developed the
most recent CBM of the P. falciparum metabolic net-
work [10] by updating their previous PlasmoNet1
model [12]. In PlasmoNet2 [10] they have added
new transport reactions based on metabolomics
Table 1: Comparison of in silico metabolic reconstructions of P. falciparum
Authors (year of publication) Information about the modela
Metabolites Reactions Genes Compartmentsb
Yeh et al. (2004) [14] 525 696 ç ç
Fatumo et al. (2009) [11] 554 575 ç ç
Huthmacher et al. (2010) [12] P: 1622 E: 566 P: 1375 E: 437 P: 579 P: c, m, a, n, r, v, g; E: e, c
Plata et al. (2010) [13] 915 1001 366 P: e, c, m, a
Bazzani et al. (2012) [10] P: 1622 H: 1149 P: 1394 H: 2539 P: 579 H: 704 P: c, m, a, n, r, v, g;H: c, r, g, l, m, n, p, b, s
The first twomodels [11,14] were built using graph-based approach and the following are constraint-basedmodels [10,12,13].
a‘P’denotes themodel of the parasite,‘E’ human erythrocyte,‘H’ human hepatocyte.
bAbbreviatednames of compartments: e, extracellular space; c, cytosol;m,mitochondrion, a, apicoplast; n, nucleus; v, digestivevacuole; r, endoplas-
mic reticulum; g,Golgi complex; l, lysosome; p, peroxisome; b, bile canaliculus; s, sinusoidal space.
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data [30] and removed one reaction according to an
updated version of KEGG database. Through inte-
gration of PlasmoNet2 with the CBM of human
hepatocyte [31], they evaluated in silico the essential-
ity of P. falciparum genes in liver stage and assessed,
using a ‘reduced fitness’ approach, effects of targeting
enzymes that are homologous and predicted to be
essential both in the host and the pathogen [10].
Comparison of the essentiality predictions made
by the aforementioned models is not a trivial task.
First, because the study by Plata et al. aimed at pre-
dicting the essentiality of genes, whereas the other
studies assessed the essentiality of enzymes, the pre-
dictions made do not overlap when gene-to-enzyme
relations are not one-to-one. Second, a gene or
enzyme may be absent from the list of ‘predicted as
essential’ not only because it has been predicted as
non-essential, but possibly, also due to the fact that
the corresponding metabolic process simply is not
included in the model of interest. Third, essentiality
predictions in CBMs are directly dependent on the
set of metabolites included into their biomass reac-
tion, so that differences in assumed biomass compos-
ition directly affect the results of in silico simulations.
For an overview of P. falciparum genes and enzymes
predicted as essential in existing models, we refer the
reader to the Supplementary Table 1. The table also
provides the reader with literature references on the
experimental assessment of genes/enzymes predicted
to be essential by the different models.
An important simplification common to all the
aforementioned models is the ad hoc assignment of
directionality to the reactions, which are pre-set
either as all reversible [12] or assumed to have the
same reversibility as in the metabolic models of non-
related organisms [13]. In principle, the directionality
of a reaction is subject to its thermodynamic proper-
ties and spurious ad hoc assignments might violate this
fundamental constraint. This issue has been addressed
rigorously in genome-scale metabolic networks of
several organisms [32–34] by implementation of
thermodynamic constraints on reaction directionality
as an extension to conventional FBA methodology.
Overall, metabolic modelling of P. falciparum to
date lags several years behind the similar efforts for
the model eukaryote S. cerevisiae; there exist a few
independently reconstructed models that often lack
consistency with each other due to the differences in
the reconstruction workflows, the sources of primary
information, the level of complexity and the varying
degree of comprehensiveness. Similarly to the trends
in modelling of the yeast metabolism, we expect the
emergence of reconciliation efforts that will aim at
obtaining a consensus, up-to-date CBM of P. falcip-
arum. Recently developed workflows for manual
[35] and semi-automated [36] reconciliations of
existing metabolic models may significantly facilitate
these efforts. There are several other areas in which
we foresee room for upcoming improvements: the
first, as mentioned before, is a systematic implemen-
tation of thermodynamic constraints in the models of
P. falciparum; the second is a deliberate revision of
the objective function (i.e. biomass reaction) to
make it consistent with the actual biomass compos-
ition of the parasite at the life stage of interest; the
third is an experimental verification and quantifica-
tion of the uptake fluxes present in the models.
These improvements are likely to make in silico pre-
dictions of gene essentiality more reliable and also
expand the number of metabolic functions currently
known to be essential for P. falciparum.
Metabolic reconstruction efforts to date have
summarized the results of decades of experimental
research on the metabolism of P. falciparum in the
form of in silico models, which not only reproduce
the prior knowledge, but also provide novel insights.
Nevertheless, the fact that cultivation of the parasite
in a fully defined medium is still impossible clearly
highlights that some important metabolic peculiari-
ties remain to be discovered. The promising direc-
tion is the utilization of the CBMs as frameworks of
current knowledge, which can then be challenged,
refined and constrained by various high-throughput
datasets as discussed in the following section.
HIGH-THROUGHPUTDATA AND
METABOLICMODELS: ‘CONTENT
FORCONTEXT’
As mentioned above, CBMs hold a great potential to
incorporate various types of experimental data as
content for the context of computational metabolic
networks. In this section of the review we provide an
outlook of the currently published studies that have
integrated computational modelling and experimen-
tal research efforts for each type of high-throughput
data introduced in Table 2.
Genomics
Genomics studies of P. falciparum have yielded so far
several complete genome sequences (for 3D7 and IT
strains [55]); however, their functional annotation
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remains far from being complete [3]. Nonetheless,
these partially annotated genomes gave rise to nu-
merous genome-wide transcriptomics and large-scale
proteomics studies as well as made possible the
reconstruction of the parasite’s metabolic network
in silico.
High-throughput functional genomics of P. falcip-
arum is a nascent field in malaria research since only
a limited number of studies have succeeded in gen-
erating single-gene mutant parasite clones at a large
scale. The largest coverage reported to date was
achieved with a forward genetics approach based
on transposon mutagenesis using the transposable
element piggyBac [56]. The collection regroups
about 200 mutant parasite lines that cover only a
modest part of the P. falciparum genome. Among
those, 24 single-gene disruptions caused severe
growth defects in vitro, which might lead to lethal
phenotypes in vivo [56]. A major drawback of this
method is its inability to reveal essential genes due
to the haploid state of the malaria parasite through-
out most of its life stages. Although specific design
of the transposon with an integrated inducible pro-
moter has been proposed to assess essential genes [6],
it still remains to be proved practicable. In contrast,
in vitro essentiality data of the genetically tractable
parasite Trypanosoma brucei have been obtained
for nearly all the coding sequences of its genome
using the RNA-interference target sequencing
approach [57].
The value of the gene essentiality datasets is
reinforced by the possibility of in silico simulation of
similar genetic perturbations. This offers reciprocal
benefits for experimental and computational
research: CBMs can often suggest the underlying
reason for viable/non-viable phenotypes of knock-
out strains and, otherwise, reveal the weak points,
where the model should be improved.
Accordingly, the algorithm GrowMatch [39] has
been applied for comparison of the high-throughput
datasets of viable/non-viable single- and double-
gene knockout mutants in S. cerevisiae with in silico
gene essentiality predictions [27]. This approach has
led to over a hundred corrections in the model (e.g.
inclusion of additional reactions, compounds and
genes as well as changes in biomass reaction), each
supported by literature evidence and largely im-
proved consistency of the model with the existing
experimental data [27]. Once a successful high-
throughput forward or reverse genetic technique is
established for P. falciparum, GrowMatch or a similar
algorithm could validate the computational model,
to improve understanding of the obtained results and
produce hypotheses for experimental investigation,
applicable to malaria drug research.
Transcriptomics
Transcriptomic profiling appears to be the one of
most common high-throughput methods applied in
malaria research; numerous gene expression datasets
are available in PlasmoDB database (http://www.
plasmodb.org) for different lineages of the parasite
under various conditions. Although the scope of
gene expression data is growing, new increasingly
advanced algorithms to integrate these datasets into
CBMs are also being developed [44]. To date, two
models of P. falciparum metabolism have incorporated
available transcriptomics data as constraints [12, 13]
to represent life-stage-specific metabolic features of
the parasite.
Huthmacher et al. integrated their model with
several life-stage-specific gene expression profiles
[40–42, 58, 59] to avoid, whenever possible, utiliza-
tion of reactions that are likely to be inactive based
on the abundance of the corresponding messenger
ribonucleic acids (mRNAs) [12]. This approach has
allowed the authors to infer plausible metabolite
exchanges between the human erythrocyte and the
Table 2: Overview of the high-throughput methods applied for functional genomics of P. falciparum and available
options for integration of the data with CBMs
Approach Examples of the methods Maximal coverage Integration with CBMs
Genomics BLASTP [2], metaSHARK [37], DETECT [38] ca. 50% Used as input data for building CBMs [25]; validation
of in silico gene essentiality [39]
Transcriptomics DNA microarray [40^42], RNA-seq [43] ca. 99% Used to constrain CBMs [12, 13]; reviewed in [44]
Proteomics 2D LC-MS/MS [45], nano-LC-MS/MS [46] ca. 45% Used to constrain CBMs [47]
Metabolomics HPLC-MS/MS [30, 48], 1H-NMR [49] ca. 15-20% Used to constrain CBMs [32, 34], reviewed in [33]
Fluxomics 13C-NMR [50, 51], 14C-NMR [52] Less than 1% Used to constrain CBMs, reviewed in [53, 54]
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parasite, as well as to predict directionality of the
pathways that cannot be easily inferred from gene
expression data alone. The predictions of the host–
parasite metabolite exchanges were in significantly
better agreement with the physiology reported in
literature when fluxes were allowed through any re-
action for which the mRNA was absent at the life-
stage-specific transcriptome but had been present
earlier (up to 12 preceding hours) [12]. This obser-
vation is consistent with the earlier study that found a
significant time delay between maximal gene expres-
sion and peak of accumulation of the corresponding
proteins [60].
Plata et al. [13] also attempted to integrate gene
expression data [30, 61] into their model to predict
the shifts in the extracellular (intraerythrocytic)
abundance of some metabolites between ring to
trophozoite and trophozoite to schizont stages. The
authors assumed that a higher influx of a metabolite
into the parasite will lower the abundance of the
substrate molecule in the cytosol of the infected
erythrocyte, whereas a higher efflux rate of a metab-
olite from the parasite will increase its intraerythro-
cytic abundance. The computational predictions
were verified against the existing metabolomics
data [30] and had an average accuracy of 70%.
With major improvements in accuracy and sensi-
tivity thresholds that can be achieved by modern
RNA-seq approaches [43], utility of transcriptomic
studies will increase significantly for experimental
and in silico functional genomics.
Proteomics
The first two large-scale proteomics datasets pub-
lished in 2002 [45, 46] provided a relatively high
coverage (ca. 45% and 23% respectively) of the ex-
pected proteome of P. falciparum [62]. While deliver-
ing only semi-quantitative results, these studies
provided the unique possibility to verify and correct
the genome annotation in terms of assignments of
open reading frames, splicing patterns and to confirm
the presence of particular enzymes in different stages
of infection.
Several approaches have been used to generate
quantitative proteomics datasets. Nirmalan et al. [63]
have established a method for fully quantitative
proteomics using [13C6
15N1]-labelled isoleucine to
recognize denovo synthesized proteins. Following this
method, Prieto et al. [64] quantified 1253 proteins in
P. falciparum trophozoites before and after exposure of
the parasite to chloroquine and artemisinin, allowing
identification of proteins involved into the parasite’s
response to treatment with these conventional anti-
malarial drugs. A recent alternative method for quan-
titative proteomics relies on externally supplied,
known amounts of proteins of interest, obtained
using QconCAT technique [65]. QconCAT-derived
proteins are labelled with heavy isotopes and serve
both as markers for identification of the similar un-
labeled proteins and a scale for their quantification
[65]. This approach offers a new level of sensitivity
and holds promise for comprehensive high-
resolution quantitative proteomics in P. falciparum.
Taking into account the complexity of the inter-
play between mRNA and protein abundances (thor-
oughly examined in [66]), the studies that combine
both transcriptomic and proteomic measurements
are of particular interest. As a result of such an inte-
grated approach applied to P. falciparum, time-delayed
correlation between peaks of transcription and max-
imal abundance of the proteins has been observed
for all the glycolytic enzymes with the exception
of enolase [60]. However, for several enzymes,
accumulation of the mRNA did not correlate with
the changes in the abundance of the corresponding
enzymes over a complete intraerythrocytic replica-
tion cycle [60]. Mair et al. [67] demonstrated that in
the Plasmodium species some genes can be transcribed
but not expressed due to translational repressions.
Despite the availability of the data and necessary
computational methods, proteomics have not been
used systematically in the development and analysis
of CBMs of P. falciparum. Meanwhile however, it has
been done for an intercellular pathogen Trypanosoma
cruzi: Roberts et al. have integrated in their CBM a
proteomics dataset that constrains fluxes through re-
actions whenever the corresponding enzyme is not
detected in life-stage-specific proteome. Using this
constraint the authors aimed at making the model
the most representative possible of the metabolic
state of the pathogen at a particular stage of its life
cycle. Initially this resulted into an over-constrained
model that was unable to simulate growth, suggesting
that even though enzymes for some reactions were
not detected in the proteome they were likely to be
present. On the other hand, constraints inferred from
the proteomics data corrected those reaction essenti-
ality predictions that were not in agreement with ex-
perimental data without these constraints [47].
Although a complex interplay between concen-
trations of mRNAs and enzymes with the fluxes
through the corresponding reactions remains to be
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elucidated, utilization of transcriptomics and prote-
omics information together can ensure higher con-
fidence that an enzyme of interest is (or is not)
present in the life stage of interest. For instance, it
is reasonable to assume that a reaction for which both
enzyme and transcripts cannot be detected is most
likely not to occur and should be tightly constrained
in the stage-specific CBMs.
Metabolomics
Several recent reviews discuss in detail the methodol-
ogies and techniques that are currently used for
metabolomics of various organisms [68–70] and mal-
aria parasites in particular [71]. The largest metabo-
lomics profile to date was obtained by liquid
chromatography coupled to a tandem mass-spec-
trometry (LC-MS/MS) analysis of both uninfected
and P. falciparum-infected human erythrocytes [30].
Relative changes in the concentrations of about 90
metabolites were monitored in both the medium
and cell lysates within a whole replication cycle,
with measurements every 8 h [30]. A further attempt
to correlate these results with gene expression data
obtained at the same time points of the infection
revealed that despite a common periodic pattern in
gene expression, only less than a third of the mea-
sured metabolite abundances fluctuated periodically
[30]. The coverage of the P. falciparum putative meta-
bolome achieved in this study is between 15% and
20% (estimated similarly to [72]) and compares with
the metabolomics of Leishmania donovani promasti-
gotes [72]. Currently, no algorithm is available to
directly incorporate the relative concentration
values in CBMs. Even so, Plata et al. used this data
as a reference to verify their in silico predictions as
discussed above. Furthermore, the dataset [30] gives
a valuable insight into actively consumed and se-
creted metabolites, an aspect of the metabolic fate
that can be used as a constraint by CBMs.
Quantification of absolute concentration values
using MS is technically possible, although it is ham-
pered by the need for a standard solution for each
metabolite [48, 73]. On the contrary, nuclear mag-
netic resonance (NMR) techniques do not require
external standards neither for identification nor for
quantification of metabolites as the integral of the
output signal is proportional to the concentration
of the studied nuclei. Despite its lower sensitivity
compared with the modern MS methods [70],
13C-NMR can identify metabolites that are other-
wise undetectable by MS due to their low ionization
potential (e.g. glycerol as reported in [74]). Using
1H-NMR, the concentrations of more than 50 me-
tabolites were measured in cell extracts of
P. falciparum trophozoites [49]. The unbiased nature
of the method also enabled identification of some
unexpected metabolites (e.g. aminobutyric acid and
buffering agent HEPES) present in relatively high
concentrations in lysates of the parasite cells [49].
An important drawback of the current metabolo-
mics studies of P. falciparum is that, for metabolites
present in more than one compartment (e.g. cyto-
solic and mitochondrial adenosine diphosphate), the
measured concentration only reflects an average
value, which may differ significantly from the
actual concentration in each of the compartments.
Metabolomics on separate organelles is an emerging
field in functional genomics research, as exemplified
in algea [75], which will enrich and verify current
knowledge on the subcellular localization of various
metabolic processes. The issue of compartmentaliza-
tion is especially complex in the case of malaria para-
sites. Indeed, these obligate intracellular parasites
develop in either hepatocytes or erythrocytes in the
intermediate host. Moreover, the parasite harbours
two symbiotic organelles: the mitochondrion and
the apicoplast (relic of a plastid organelle acquired
by engulfment of an algae), both of which are host
metabolic pathways that are crucial to the central
carbon metabolism of P. falciparum.
Fluxomics
Fluxomics is a largely unexplored area in malaria
research, while for experimentally amenable species
it represents a relatively well-established and rapidly
developing field [53, 54]. Incorporation of the mea-
sured values of flux through the reactions present in
CBMs can significantly improve the accuracy of the
models by reducing the uncertainty in the ranges and
distributions of metabolic fluxes. To the best of our
knowledge, the only fluxomics studies in P. falcip-
arum, to date, are the assessments of influx rates for
single substrates: glucose (in infected and non-in-
fected human erythrocytes [50, 51]), isoleucine
[76], pantothenate [52] and inorganic phosphate
[77]. Due to the indispensability of these substrates
for the parasite, incorporation of these flux values
may represent overriding constraints for the CBMs.
In the case of model organisms, e.g. S. cerevisiae,
measured metabolic fluxes were included into the
CBMs and allowed in silico resolution of experimen-
tally observed metabolic features that could not be
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inferred otherwise—neither from transcriptomics
nor proteomics data [54]. A relevant example is a
large increase in glycolytic flux, which can be main-
tained by the yeast exposed at low levels of oxygen
without changing the expression levels for involved
genes [78]. This led to an important conclusion that
fluxes in primary metabolism are more likely to be
controlled via regulation of enzymatic activities and
not by changes in gene expression as in secondary
metabolism [54].
Overall, out of numerous methods developed for
the integration of experimental data with CBMs,
only a modest proportion have hitherto been applied
to pathogenic organisms and P. falciparum in particu-
lar. We argue that this is not only due to the com-
plexity of the experimental study of pathogens, but
also due to the fact that a majority of the in silico
methods discussed above were initially designed for
free-living organisms. Although the methods are, in
principle, applicable to intracellular pathogens, some
aspects unique to the parasites may be crucial for
obtaining relevant computational results. Examples
of such aspects would be the common absence of a
clearly defined set of substrates and by-products for
the metabolism of intracellular parasites, the changes
in composition of biomass across multiple stages of
their life cycles or sub-optimal utilization of available
substrates, etc. These issues and the aforementioned
experimental challenges represent the area where
we expect forthcoming improvements, leading to a
better understanding of metabolic peculiarities
encoded in the genome of P. falciparum.
FUTUREDIRECTIONS
Obligate intracellular parasitism of P. falciparum
represents a significant challenge for medical treat-
ment, as it is virtually impossible to avoid impact of
antimalarial drugs on the host. Thus, high selectivity
is an essential prerequisite for all potential drug can-
didates. However, many of the genes and enzymes
predicted as being essential in P. falciparum do possess
a variable level of sequence identity to their human
counterparts [10, 12, 13], suggesting that an interfer-
ence with them may also affect uninfected host
cells. To assess this phenomenon insilico, the ‘reduced
fitness’ approach was applied by Bazzani et al. [10]
to the CBM of P. falciparum embedded into the
model of a human hepatocyte. This method can
estimate quantitatively how production of biomass
would be affected in the host and the parasite’s meta-
bolic networks when the flux through a targeted
reaction is gradually reduced to the same extent in
both models. Although it shows a purely theoretical
sensitivity of the host and the parasite to inhibition of
a certain enzymatic activity, this approach should be
considered with caution as it neglects some import-
ant aspects, which cannot be captured by CBMs.
FBA is indeed suitable for simulation of the out-
comes for gene knockout experiments, when tar-
geted enzymatic activity is abolished completely.
However, a realistic simulation of the effects of
reduced enzymatic activity (i.e. action of a drug)
requires careful consideration of kinetic and thermo-
dynamics properties. Ultimately, even if one assumes
identical kinetic properties for inhibited enzymes in
the infected host cell and its parasite, sensitivity of the
flux through the catalyzed reaction to the same
amount of inhibitor can be different simply if the
expression level of this enzyme is not the same in
these organisms [79].
Metabolic control analysis (MCA) considers all
the relevant properties to provide a more realistic
estimation about the extent to which flux through
a reaction of interest is sensitive to the action of an
inhibitor [80–82]. Using the methodologies from
MCA, one can also predict whether the inhibition
of a target enzyme will have a selective effect on the
parasite relative to its host. Using kinetic modelling
and MCA, Bakker et al. [83] have demonstrated
that glyceraldehyde-3-phosphate dehydrogenase
and phosphoglycerate kinase may represent promis-
ing targets for the treatment of sleeping sickness due
to drastically different susceptibility of glycolytic
fluxes to inhibition of these enzymes in human and
in African trypanosome.
A major limiting factor for application of MCA to
metabolic models of P. falciparum is the need to inte-
grate the kinetic parameters of enzymes in the model
and the concentration profile of key metabolites [84].
To date, such experimental information exists only
for a modest part of the CBMs of a relatively small
number of organisms [85], which is of limited
applicability [86, 87]. The recently developed
ORACLE framework can be used to perform
MCA under significant uncertainty to provide a
guidance and a quantitative ranking for drug target
identification [84]. Kinetic modelling and MCA
represent the next promising field of research for a
fine-grained evaluation of the pathways that contain
in silico predicted drug targets. These efforts may also
provide a valuable guidance for further development
in the functional genomics of P. falciparum, whereas
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analytical technologies will provide the information
necessary for building a kinetic model of its meta-
bolic network.
SUPPLEMENTARYDATA
Supplementary data are available online at http://
bib.oxfordjournals.org/
Key Points
 Modelling efforts in P. falciparum focused on revealing indispens-
able metabolic functions have expanded the list of putatively
essential genes and enzymes.
 Interpretation of high-throughput data in the context of CBMs
yields new, non-intuitive insights about functions of metabolic
genes and offers testable hypotheses for experimental research.
 Kinetic modelling approaches will enable the integration of a
broadrange of data from functional genomics, such asmetabolo-
mics, and address the limitations of the CBMs.
 Reliable kinetic modes of metabolic networks will accelerate
drug target identification and rational drug development.
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